PFIZER INC.
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2018-09-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1022
- Registration Number
- NCT01210482
- Locations
- π―π΅
Kyusyu University Hospital, Fukuoka-shi, Fukuoka PREF, Japan
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2019-01-09
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 224
- Registration Number
- NCT01210495
- Locations
- πΊπΈ
Moores UCSD Cancer Center, La Jolla, California, United States
πΊπΈUCSD Medical Center- La Jolla, La Jolla, California, United States
πΊπΈComprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2011-12-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2
- Registration Number
- NCT01210443
- Locations
- π―π΅
Pfizer Investigational Site, Shinjyuku-ku, Tokyo, Japan
Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2011-06-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT01210404
- Locations
- πΊπΈ
Pfizer Investigational Site, Overland Park, Kansas, United States
Prevenar (PCV-7) Post-Licensure Safety Study In Russia
- Conditions
- Healthy Children After Vaccination
- Interventions
- Other: Non-interventional observational study
- First Posted Date
- 2010-09-23
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 100
- Registration Number
- NCT01207583
- Locations
- π·πΊ
Russian Academy of Medical Sciences, Moscow, Russian Federation
π·πΊRussian State Medical University, Moscow, Russian Federation
π·πΊResearch Institute of Childhood Infections, Saint Petersburg, Russian Federation
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
- First Posted Date
- 2010-09-23
- Last Posted Date
- 2016-02-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 181
- Registration Number
- NCT01208233
- Locations
- πΊπΈ
Spain Rehabilitation Center, Birmingham, Alabama, United States
πΊπΈNeurostudies, Inc., Port Charlotte, Florida, United States
πΊπΈNorwood Nursing Center, Huntington, Indiana, United States
Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers
- First Posted Date
- 2010-09-17
- Last Posted Date
- 2010-10-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT01204112
- Locations
- πΊπΈ
Pfizer Investigational Site, New Haven, Connecticut, United States
A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients
- First Posted Date
- 2010-09-17
- Last Posted Date
- 2011-12-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2
- Registration Number
- NCT01204853
- Locations
- π―π΅
Pfizer Investigational Site, Shinjyuku-ku, Tokyo, Japan
Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2014-04-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 50
- Registration Number
- NCT01202253
- Locations
- π¬π§
Pfizer Investigational Site, London, United Kingdom
Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2011-02-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT01202240
- Locations
- π§πͺ
Pfizer Investigational Site, Bruxelles, Belgium